Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference24 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
2. National Cancer Institute. Cancer Stat Facts: Prostate Cancer. National Cancer Institute Surveillance, Epidemiology, and End Results Program. Published n.d. Accessed 30 April 2020. https://seer.cancer.gov/statfacts/html/prost.html
3. Bernard B, Burnett C, Sweeney CJ, Rider JR, Sridhar SS Impact of age at diagnosis of de novo metastatic prostate cancer on survival. Cancer. Published online 2019. https://doi.org/10.1002/cncr.32630
4. James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, et al. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet 2016;387:1163–77.
5. Sweeney CJ, Chen Y-H, Carducci M, Liu G, Jarrard DF, Eisenberger M, et al. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. 2015;373:737–46.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献